Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study

Tina BhutaniDepartment of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA, USACorrespondence[email protected]

Faranak KamangarDepartment of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA, USA

Kristine ZitelliDepartment of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA, USA

Charles ChiangDepartment of Dermatology, Wright State University, Fairborn, OH, USA

Shilpa GattuDepartment of Dermatology, University of California, San Diego, CA, USA

Thao NguyenDepartment of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, USA

Emily BeckerDepartment of Dermatology, UT Southwestern, San Antonio, TX, USA

John KooDepartment of Dermatology, University of California, UCSF Psoriasis and Skin Treatment Center, San Francisco, CA, USA

show all

References

Koo J. Population based epidemiologic study of psoriasis with emphasis on quality of life assesment. Dermatol Clin. 1996;14:485–496.
PubMed Web of Science ®Google Scholar
van de Kerkhof P, Griffiths CE, Christophers E, Lebwohl M, Krueger GG. Alefacept in the treatment of psoriasis for whom conventional therapies are inaqequate. Dermatology. 2005;211:256–263.
PubMed Web of Science ®Google Scholar
Chaarani J, Lebwohl M. Alefacept: where it stands today. Expert Opin Drug Metab Toxicol. 2010;6:355–361.
PubMed Web of Science ®Google Scholar
Ortonne JP. Clinical response to alefacept: results of a phase 3 study of intravenous administration of alefacept in patients with chronic plaque psoriasis. J Eur Acad Dermatol Venereol. 2003;17(Suppl 2):17–24.
PubMedGoogle Scholar
Krueger GG, Papp KA, Stough DB. A randomized, double blind, placebo controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2002;47:821–833.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intralesional injections of alefacept may predict systemic response to intramuscular alefacept: results from a pilot study

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date